Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis

IntroductionAsthma associated with eosinophilic granulomatosis with polyangiitis (EGPA) is often severe and corticosteroid-dependent, leading to significant morbidity. Mepolizumab and benralizumab are humanized monoclonal antibodies targeting interleukin 5 (IL-5) and its receptor, respectively. They...

詳細記述

書誌詳細

出版年:	Frontiers in Medicine
主要な著者:	Charlene Desaintjean, Kaïs Ahmad, Julie Traclet, Mathieu Gerfaud-Valentin, Cecile-Audrey Durel, Jean-Charles Glerant, Arnaud Hot, François Lestelle, Sabine Mainbourg, Mouhamad Nasser, Pascal Seve, Ségolène Turquier, Gilles Devouassoux, Vincent Cottin
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2024-03-01
主題:	Interleukin-5 vasculitis eosinophil asthma corticosteroids granulomatosis
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1341310/full